SIREN : 479771040
XTREM SANTE is a French company founded 21 years ago, specialized in the sector Conseil en systèmes et logiciels informatiques. Based in PERIGNY (17180), this company of category ETI shows in 2024 a revenue of 10.5 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10 526 639 € | 10 216 607 € | 5 850 185 € | 4 553 231 € | 3 870 255 € | 611 309 € | 2 858 172 € | 2 675 304 € | 2 183 353 € | 1 716 959 € |
| Net income | 687 046 € | 1 946 211 € | 392 578 € | 243 653 € | 85 010 € | -164 120 € | 331 526 € | 371 437 € | 357 179 € | 243 937 € |
| EBITDA | 1 541 683 € | 1 475 817 € | 563 288 € | 572 763 € | 507 804 € | -158 697 € | 492 146 € | 675 670 € | 518 707 € | 379 411 € |
| Net margin | 6.5% | 19.0% | 6.7% | 5.4% | 2.2% | -26.8% | 11.6% | 13.9% | 16.4% | 14.2% |
In 2024, XTREM SANTE achieves revenue of 10.5 M€. Over the period 2016-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +25.4%. Vs 2023: +3%. After deducting consumption (952 k€), gross margin stands at 9.6 M€, i.e. a rate of 91%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 1.5 M€, representing 14.6% of revenue. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 687 k€, i.e. 6.5% of revenue. This profit can be retained or distributed to shareholders.
10 526 639 €
9 574 143 €
1 541 683 €
857 383 €
687 046 €
14.6%
The debt ratio (= Financial debt / Equity x 100) stands at 1%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 23%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.0 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 13.0% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
0.617%
23.095%
13.028%
0.019
26.1%
In 2024, the debt ratio of XTREM SANTE (0.62) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2024, the financial autonomy of XTREM SANTE (23.1%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of XTREM SANTE (0.02) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 62.86. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 36.9x. Operating income very largely covers interest expenses: high safety margin.
62.86
36.909
In 2024, the liquidity ratio of XTREM SANTE (62.86) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
In 2024, the interest coverage of XTREM SANTE (36.9x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 131 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 221 days. Excellent situation: suppliers finance 90 days of the operating cycle (retail model). WCR is negative (-106 days): operations structurally generate cash. Notable WCR improvement over the period (-860%), freeing up cash.
-3 096 937 €
131 j
221 j
0 j
-106 j
Based on 215 transactions of similar company sales (all years), the value of XTREM SANTE is estimated at 1 462 455 € (range 643 849€ - 4 848 016€). With an EBITDA of 1 541 683€, the sector multiple of 1.0x is applied. The price/revenue ratio is 0.16x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare XTREM SANTE with other companies in the same sector:
Voir toutes les statistiques du secteur Conseil en systèmes et logiciels informatiques
The revenue of XTREM SANTE in 2024 is 10.5 M€.
Yes, XTREM SANTE generated a net profit of 687 k€ in 2024.
The headquarters of XTREM SANTE is located in PERIGNY (17180), in the department Charente-Maritime.
The tax return of XTREM SANTE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
XTREM SANTE operates in the sector Conseil en systèmes et logiciels informatiques (NAF code 62.02A). See the 'Sector positioning' section above to compare the company with its competitors.